Krognes Steve E.

EDGAR CIK 0001666236

Denali Therapeutics Inc. - DNLI

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Director
Direct Buys
0
$0
0 Shares
Direct Sells
1
($69,485)
-3,339 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/07/2025
01/08/2025
Sell
-3,339 @ $20.81
 ($69,485) 25,757 (-11.48%) Direct